JAK Inhibitors and Oxidative Stress Control

Primary Sjögren's syndrome (SjS) is a complex autoimmune epithelitis, with few treatment options, but the use of Janus kinase (JAK) inhibitors is promising because suppression of the JAK/signal transducer and activator of transcription (STAT) pathway improves sicca manifestations. Playing a pri...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Charras, Amandine, Arvaniti, Pinelopi, Le Dantec, Christelle, Dalekos, George N., Zachou, Kaliopi, Bordron, Anne, Renaudineau, Yves
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2019
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6908489/
https://ncbi.nlm.nih.gov/pubmed/31867003
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2019.02814
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller